Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Exelixis Inc (EXEL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Exelixis's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
22.49 -0.38    -1.66%
18/04 - Closed. Currency in USD ( Disclaimer )
After Hours
23.12
+0.63
+2.80%
19:57:20 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,495,016
  • Bid/Ask: 22.50 / 23.13
  • Day's Range: 22.46 - 23.23
Exelixis 22.49 -0.38 -1.66%

EXEL Ratios

 
Assess the performance of Exelixis (EXEL). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Exelixis Inc's latest financial reports. Compare the performance metrics of Exelixis (EXEL) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 31.91 0.72
Price to Sales TTM 3.62 716.27
Price to Cash Flow MRQ 19.89 2.4
Price to Free Cash Flow TTM 22.64 -13.21
Price to Book MRQ 2.93 4.31
Price to Tangible Book MRQ 3.15 1.69
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 96.04% -4,938.09
Gross Margin 5YA 96.43% -983.54
Operating margin TTM 9.34% -9,610
Operating margin 5YA 21.39% -2,917.21
Pretax margin TTM 14.07% -9,099.6
Pretax margin 5YA 23.62% -1,740.8
Net Profit margin TTM 11.35% -9,093.98
Net Profit margin 5YA 23.77% -4,772.71
   
Revenue/Share TTM 5.89 38.23
Basic EPS ANN 0.65 7.33
Diluted EPS ANN 0.65 6.96
Book Value/Share MRQ 7.28 63.04
Tangible Book Value/Share MRQ 7.27 47.77
Cash/Share MRQ 0.85 17.5
Cash Flow/Share TTM 1.07 9.15
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 8.74% -39.63
Return on Equity 5YA 17.1% -66.96
Return on Assets TTM 6.91% -13.87
Return on Assets 5YA 15.02% -11.93
Return on Investment TTM 5.35% -8.99
Return on Investment 5YA 11.83% -8.37
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 397% -20.73
EPS(TTM) vs TTM 1 Yr. Ago TTM 15.19% -71.86
5 Year EPS Growth 5YA -22.37% 6.03
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 13.15% 476.19
Sales (TTM) vs TTM 1 Yr. Ago TTM 13.6% 52.24
5 Year Sales Growth 5YA 16.47% 31.23
5 Year Capital Spending Growth 5YA 3.98% 20.56
   
Quick Ratio MRQ 3.13 6
Current Ratio MRQ 3.34 6.34
LT Debt to Equity MRQ - 39.81
Total Debt to Equity MRQ 9.53% 1.98
Efficiency    
Asset Turnover TTM 0.61 0.32
Inventory Turnover TTM 2.87 5.96
Revenue/Employee TTM 1.40M 608.57K
Net Income/Employee TTM 158.60K -401.07K
Receivable Turnover TTM 7.9 6.7
   
Dividend Yield ANN - 0.03
Dividend Yield 5 Year Avg. 5YA - 0.03
Dividend Growth Rate ANN 0% 0.8
Payout Ratio TTM - 1.83
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EXEL Comments

Write your thoughts about Exelixis Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Chiaretto Calo
Chiaretto Calo Feb 23, 2024 9:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$EXEL Bullish despite Cabometyx patent battles -- Insider buy gives a good indication of potential outcome? :-))
Simone Lancisi
Simone Lancisi Jan 25, 2022 12:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Market Mìracle advisor has published a BUY signal with target 21.358
Karim Davarpanah
Karim Davarpanah Sep 17, 2021 5:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🚀🚀🚀FDA approves Exelixis thyroid cancer treatment
Patricio Garnica
Patricio Garnica Jun 28, 2021 2:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dog
Jay Clays
Jay Clays Jun 28, 2021 2:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Patricio, acaso vives en Valencia, España? Es que conozco a un Patricio Garnica x'D
Ali Daher
Ali Daher Mar 26, 2021 9:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Exel was supposed to be a great investment. I hope it goes to 30 like expected
AR PCPRO
AR PCPRO Feb 15, 2021 8:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any update on this one?
Jay Clays
Jay Clays Nov 17, 2020 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great balance sheet, this stock seems quite undervalued! Just added some more to my portfolio at $19 :D
Maxim Kamyshev
Maxim Kamyshev Feb 25, 2020 11:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good report! I think time to buy!
Timmy Vo
Timmy Vo Feb 24, 2020 4:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
president and CEO are selling their shares right before earning report. ain't good
John Tirita
John Tirita Nov 13, 2019 12:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going to the place it belongs, up!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email